Evaluation of Beneficial Effects of Melilotus officinalis on Blood Profiles in iron Overloaded Sprague Dawley Rats

Authors

  • N.A. Sheikh Hi-Tech College of Pharmacy, Chandrapur-442406, Maharashtra, India
  • S.B. Kosalge Hi-Tech College of Pharmacy, Chandrapur-442406, Maharashtra, India
  • T.R. Desai School of Pharmacy, RK University, Rajkot-360020, Gujarat, India
  • A.P. Dewani P. Wadhwani College of Pharmacy, Yavatmal-445001, Maharashtra, India
  • D.S. Mohale P. Wadhwani College of Pharmacy, Yavatmal-445001, Maharashtra, India
  • A.S. Tripathi Institute of Pharmacy, Amity University, Noida, Uttar Pradesh, India

DOI:

https://doi.org/10.12974/2312-5411.2020.07.5

Keywords:

Melilotus officinalis, Haematological parameters, Iron overload, Sprague Dawley Rats.

Abstract

Present study deals with the investigation of beneficial effects of different fraction of Melilotus officinalis (M. officinalis) on the toxic effects of iron on different blood parameters in iron overloaded sprague dawley rats. The six IP injections of iron dextran (12.5 mg/100g) were administered uniformly over a period of 30 days to induce iron overload. Different fractions of M. officinalis were given orally and Deferoxamine (DFO) subcutaneously for 30 days. The blood parameters were estimated on 15th and 30th day of treatment. Rats exposed to iron showed significant (p < 0.01) decrease in RBC counts, Total and Differential WBC counts and Platelet counts. This indicates that excess of iron in iron overloaded disease can leads to bone marrow suppression. The animals treated with methanolic fraction of methanolic extract (MFME) and methanolic fraction of aqueous extract (MFAE) of M. officinalis shows significant (P<0.01) improvement in haematological parameters as compared to disease control (DC) rats. Greater beneficial effects were observed on 30th day and at higher dose (300 mg/kg) as compared to 15th day and at lower dose (150 mg/kg). These results suggested that M. officinalis have beneficial effects on blood parameters in iron intoxicated rats. 

References

Anwer MS, Mohtasheem M, Azhar I, et al. Chemical constituents from Melilotus officinalis. J Basic App Sci 2008; 4: 89-94

Sheikh NA, Desai TR, Patel RD. Pharmacognostic evaluation of Melilotus officinalis Linn. Pharmacogn J 2016; 8: 239-242 https://doi.org/10.5530/pj.2016.3.11

Sheikh NA, Desai TR, Tirgar PR. Investigation into iron chelating and antioxidant potential of Melilotus officinalis in iron dextran induced iron overloaded Sprague Dawley rat model. Drug Res (Stuttg) 2016; 66: 618-627 https://doi.org/10.1055/s-0042-113182

Karakas FP, Yildirim A, Turker A. Biological screening of various medicinal plant extracts for antibacterial and antitumor activities. Turk J Biol 2012; 36: 641-652

Luminit PM, Parvu AE, Parvu M et al. Effects of Melilotus officinalis on acute inflammation. Phytother Res 2002; 16: 316-319 https://doi.org/10.1002/ptr.875

Anwer MS, Shamim S, Ahmed S et al. Hypotensive activity of Melilotus officinalis (L.) Pallas. Eur J Med Series B 2015; 3: 80-85 https://doi.org/10.13187/ejm.s.b.2015.3.80

Nadkarni AK. Indian materia medica. 3rd ed. volume I. Mumbai: Popular Prakashan, 2007: 786

Kirtikar KR, Basu BD. Indian medicinal plants. 2nd ed. volume I. Dehradun: International Book Distributors, 2005: 704-705

Anonymous. The wealth of India. A dictionary of Indian raw materials and industrial products. Volume 6 (L-M). New Delhi: CSIR, 2003: 331

Pietrangelo A. Haemochromatosis. Gut 2003; 52: Suppl II ii23-ii30. https://doi.org/10.1136/gut.52.suppl_2.ii23

Papanikolaou G, Pantopoulos K. Iron metabolism and toxicity. Toxicol Appl Pharm 2005; 202: 199-211 https://doi.org/10.1016/j.taap.2004.06.021

Siddique A, Kowdley KV. Review article: the iron overload syndromes. Aliment Pharmacol Ther 2012; 35: 876-893 https://doi.org/10.1111/j.1365-2036.2012.05051.x

Dimitriou E, Kairis M, Sarafidou J, et al. Iron overload and kidney lysosomes. Biochim Biophys Acta 2000; 1501: 138- 148 https://doi.org/10.1016/S0925-4439(00)00019-3

Schipper HM. Neurodegeneration with brain iron accumulation-clinical syndromes and neuroimaging. Biochim Biophys Acta 2012; 1822: 350-360 https://doi.org/10.1016/j.bbadis.2011.06.016

Ong CK, Lim SL, Tan WC, et al. Endocrine complications in transfusion dependent thalassaemia in Penang hospital. Med J Malaysia 2008; 63: 109-112

Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis 2010; 5: 1-15 https://doi.org/10.1186/1750-1172-5-11

Porter JB. Practical management of iron overload. Brit J Haematol 2001; 115: 239-252 https://doi.org/10.1046/j.1365-2141.2001.03195.x

Hatcher HC, Singh RN, Torti FM, et al. Synthetic and natural iron chelators: therapeutic potential and clinical use. Future Med Chem 2009; 1: 1643-1670. https://doi.org/10.4155/fmc.09.121

Kokate CK. Practical Pharmacognosy. 4th ed. New Delhi: Vallabh Prakashan, 2004: 136-154

Ibrahim NG, Hoffstein ST, Freedman ML. Induction of liver cell haem oxygenase in iron-overloaded rats. Biochem J 1979; 180: 257-263 https://doi.org/10.1042/bj1800257

Kushner JP, Porter JP, Olivieri NF. Secondary iron overload. Hematology 2001; 2001: 47-61 https://doi.org/10.1182/asheducation-2001.1.47

Osei-Bimpong A, McLean R, Bhonda E, et al. The use of the white cell count and haemoglobin in combination as an effective screen to predict the normality of the full blood count. Int J Lab Hematol. 2012; 34: 91-97 https://doi.org/10.1111/j.1751-553X.2011.01365.x

Symonowicz M, Kolanek M. Flavonoids and their properties to form chelate complexes. Biotechnol Food Sci 2012; 76: 35-41

Ebrahimzadeh MA, Pourmorad F, Bekhradnia AR. Iron chelating activity, phenol and flavonoid content of some medicinal plants from Iran. Afr J Biotechno 2008; 7: 3188- 3192

Ghasemzadeh A, Ghasemzadeh N. Flavonoids and phenolic acids: Role and biochemical activity in plants and human. J Med Plants Res 2011; 5: 6697-6703 https://doi.org/10.5897/JMPR11.1404

Pourmorad F, Hosseinimehr SJ, Shahabimajd N. Antioxidant activity, phenol and flavonoid contents of some selected Iranian medicinal plants. Afr J Biotechnol 2006; 5: 1142-1145

Weatherall DJ. The thalassaemias. Brit Med J 1997; 314(7095): 1675-1678 https://doi.org/10.1136/bmj.314.7095.1675

Oliva EN, Ronco F, Marino A, et al. Iron chelation therapy associated with improvement of hematopoiesis in transfusion-dependent patients. Transfusion. 2010; 50(7): 1568-1570 https://doi.org/10.1111/j.1537-2995.2010.02617.x

Walker EM Jr, Walker SM. Effects of iron overload on the immune system. Ann Clin Lab Sci 2000; 30(4): 354-365 https://doi.org/10.1023/A:1003905109007

Mencacci A, Cenci E, Boelaert JR, et al. Iron overload alters innate and T-helper cell response to Candida albicans in mice. J Infect Dis 1997; 175(6): 1467-1476 https://doi.org/10.1086/516481

Dahi AA, Hanafy E, Pakra MA. Iron Overload and Platelet Function Defects: Possible Correlation. J Invest Med High Impact Case Rep 2016; 4(4): 1-4 https://doi.org/10.1177/2324709616675645

Jensen PD, Heickendorff L, Pedersen B, et al. The effect of iron chelation on hematopoiesis in MDS patients with transfusional iron overload. Br J Haematol 1996; 94(2): 288- 299 https://doi.org/10.1046/j.1365-2141.1996.d01-1795.x

Downloads

Published

2020-06-06

How to Cite

Sheikh, N., Kosalge, S., Desai, T., Dewani, A., Mohale, D., & Tripathi, A. (2020). Evaluation of Beneficial Effects of Melilotus officinalis on Blood Profiles in iron Overloaded Sprague Dawley Rats. Journal of Hematology Research, 7, 23–30. https://doi.org/10.12974/2312-5411.2020.07.5

Issue

Vol. 7 (2020)

Section

Articles